NCT00724724

The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1,000 (estimated)
• Sponsor: Peking Union Medical College Hospital · Academic / Other
• Sex: All
• Age: 40 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to evaluate the efficacy and safety of Butylphthalide Soft Capsules (En Bi Pu, NBP) in Secondary Prevention of Ischemic Stroke

Detailed description

The efficacy and safety of Butylphthalide Soft Capsules (En Bi Pu, NBP)in acute ischemic stroke has been demonstrated in China recently. Its role in secondary prevention of ischemic stroke need to be evaluated.

Conditions

• Stroke
• Transient Ischemic Attack

Interventions

Type	Name	Description
DRUG	Butylphthalide Soft Capsules	Butylphthalide Soft Capsules: 2 tablets Bid for 1 year Aspirin: 100mg for 1 year
DRUG	Aspirin	Aspirin 100mg Qd for 1 year

Timeline

• Start date: 2008-08-01
• Primary completion: 2011-06-01
• Completion: 2011-08-01
• First posted: 2008-07-29
• Last updated: 2011-02-24

Locations

50 sites across 1 country: China